The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin
Abstract
Random phage display peptide libraries and affinity selective methods were used to isolate small peptides that bind to and activate the receptor for the cytokine erythropoietin (EPO). In a panel of in vitro biological assays, the peptides act as full agonists and they can also stimulate erythropoiesis in mice. These agonists are represented by a 14- amino acid disulfide-bonded, cyclic peptide with the minimum consensus sequence YXCXXGPXTWXCXP, where X represents positions allowing occupation by several amino acids. The amino acid sequences of these peptides are not found in the primary sequence of EPO. The signaling pathways activated by these peptides appear to be identical to those induced by the natural ligand. This discovery may form the basis for the design of small molecule mimetics of EPO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Guzman, L. M., Belin, D., Carson, M. J., & Beckwith, J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4121-4130.1995 · Cited by 4,935
DeLean, A., Munson, P. J., & Rodbard, D. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.235.2.e97 · Cited by 2,374
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
Searching for Peptide Ligands with an Epitope Library
Scott, J. K., & Smith, G. P. (1990) · Science · doi:10.1126/science.1696028 · Cited by 2,084
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Yi, T., Tang, B., Miura, O., & Ihle, J. N. (1993) · Cell · doi:10.1016/0092-8674(93)90414-l · Cited by 1,194
Erythropoietin: structure, control of production, and function
Jelkmann, W. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.2.449 · Cited by 1,151
Gordon, E. M., Barrett, R. W., Dower, W. J., Fodor, S. P. A., & Gallop, M. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00036a001 · Cited by 1,142
Self-citation
Cited by
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
Cyclic peptide therapeutics: past, present and future
Zorzi, A., Deyle, K., & Heinis, C. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.02.006 · Cited by 737
A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice
Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T., & Petit, E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00007 · Cited by 715
Convergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Erythropoietin Receptor Activation by a Ligand-Induced Conformation Change
Remy, I., Wilson, I. A., & Michnick, S. W. (1999) · Science · doi:10.1126/science.283.5404.990 · Cited by 634
Crystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation
Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., & Wilson, I. A. (1999) · Science · doi:10.1126/science.283.5404.987 · Cited by 599
Self-citationFunctional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å
Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., & Wilson, I. A. (1996) · Science · doi:10.1126/science.273.5274.464 · Cited by 588
Self-citationUnderstanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Efficiency of signalling through cytokine receptors depends critically on receptor orientation
Syed, R. S., Reid, S. W., Li, C., Cheetham, J. C., Aoki, K. H., Liu, B., Zhan, H., Osslund, T. D., Chirino, A. J., Zhang, J., et al. (1998) · Nature · doi:10.1038/26773 · Cited by 551
Challenges for the oral delivery of macromolecules
Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
Rajotte, D., Arap, W., Hagedorn, M., Koivunen, E., Pasqualini, R., & Ruoslahti, E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3008 · Cited by 457
Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., & Kim, P. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80066-5 · Cited by 442
Chemical genetics: ligand-based discovery of gene function
Stockwell, B. R. (2000) · Nature Reviews Genetics · doi:10.1038/35038557 · Cited by 421
[21] Phage display for selection of novel binding peptides
Sidhu, S. S., Lowman, H. B., Cunningham, B. C., & Wells, J. A. (2000) · Methods in Enzymology · doi:10.1016/s0076-6879(00)28406-1 · Cited by 406
Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural Cytokine
Cwirla, S. E., Balasubramanian, P., Duffin, D. J., Wagstrom, C. R., Gates, C. M., Singer, S. C., Davis, A. M., Tansik, R. L., Mattheakis, L. C., Boytos, C. M., et al. (1997) · Science · doi:10.1126/science.276.5319.1696 · Cited by 403
Self-citationPhotodegradable, Photoadaptable Hydrogels via Radical-Mediated Disulfide Fragmentation Reaction
Fairbanks, B. D., Singh, S. P., Bowman, C. N., & Anseth, K. S. (2011) · Macromolecules · doi:10.1021/ma200202w · Cited by 378
Erythropoietin after a century of research: younger than ever
Jelkmann, W. (2007) · European Journal of Haematology · doi:10.1111/j.1600-0609.2007.00818.x · Cited by 367
Therapeutic peptides: technological advances driving peptides into development
Sato, A. K., Viswanathan, M., Kent, R. B., & Wood, C. R. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.10.002 · Cited by 362
Advancement and applications of peptide phage display technology in biomedical science
Wu, C.-H., Liu, I.-J., Lu, R.-M., & Wu, H.-C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0223-x · Cited by 339
Discovering and improving novel peptide therapeutics
MCGREGOR, D. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.002 · Cited by 331
Pardridge, W. M. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199707000-00001 · Cited by 328
Agnati, L. F., Ferré, S., Lluis, C., Franco, R., & Fuxe, K. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.2 · Cited by 323
Filamentous Bacteriophage: Biology, Phage Display and Nanotechnology Applications
(2011) · Current Issues in Molecular Biology · doi:10.21775/cimb.013.051 · Cited by 321
Peptide-based drug discovery: Current status and recent advances
Sharma, K., Sharma, K. K., Sharma, A., & Jain, R. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103464 · Cited by 313
Timmerman, P., Beld, J., Puijk, W. C., & Meloen, R. H. (2005) · ChemBioChem · doi:10.1002/cbic.200400374 · Cited by 295
Anemia: progress in molecular mechanisms and therapies
Sankaran, V. G., & Weiss, M. J. (2015) · Nature Medicine · doi:10.1038/nm.3814 · Cited by 281
Clackson, T., Ultsch, M. H., Wells, J. A., & de Vos, A. M. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1669 · Cited by 278
Designing a polyvalent inhibitor of anthrax toxin
Mourez, M., Kane, R. S., Mogridge, J., Metallo, S., Deschatelets, P., Sellman, B. R., Whitesides, G. M., & Collier, R. J. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-958 · Cited by 272
Li, L., Milner, L. A., Deng, Y., Iwata, M., Banta, A., Graf, L., Marcovina, S., Friedman, C., Trask, B. J., Hood, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80457-4 · Cited by 269
He, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.5132 · Cited by 266
Constantinescu, S. N., Keren, T., Socolovsky, M., Nam, H.-S., Henis, Y. I., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081069198 · Cited by 260
Houdebine, L. M. (2000) · Transgenic Research · doi:10.1023/a:1008934912555 · Cited by 255
Bunn, H. F. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011619 · Cited by 234
The pleiotropic effects of erythropoietin in infection and inflammation
Nairz, M., Sonnweber, T., Schroll, A., Theurl, I., & Weiss, G. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.005 · Cited by 161
Vascular growth factors in neuropsychiatry
Newton, S. S., Fournier, N. M., & Duman, R. S. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1281-9 · Cited by 48
“Initial studies were performed using phage display methodology to identify peptides that exhibited strong EPO mimetic actions [136].”
Method
Metadata
- Authors
- Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K., & Dower, W. J.
- Venue
- Science
- Published
- 1996-07-26
- Volume
- 273
- Issue
- 5274
- Pages
- 458-463
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1987888718
- Cited by
- 672
- References
- 43
- FWCI
- 33.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.